Clinical trial
Ticagrelor Plus Aspirin vs Clopidogrel Plus Aspirin in Mild Non-cardioembolic Ischemic Stroke: A Randomized, Active Comparator Arm, Outcome Assessor Blind, Controlled, Feasibility Study
NCT04738097 is registered in ClinicalTrials.gov with Mazandaran University of Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ticagrelor Plus Aspirin vs Clopidogrel Plus Aspirin in Mild Non-cardioembolic Ischemic Stroke: A Randomized, Active Comparator Arm, Outcome Assessor Blind, Controlled, Feasibility Study
- Lead sponsor
- Mazandaran University of Medical Sciences
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- August 8, 2021
- Completion date
- October 15, 2023
- Enrollment
- 90 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
ischemic stroke, transient ischemic attack